Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
United Maritime Updates on Tanker Delivery Schedule and Announces Closing of Previously Announced Equity Offering at $3.25 per Unit
-
Acurx Pharmaceuticals (ACXP) Announces 1.3M Share Offering at $3.25/sh
-
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
-
Boxlight Corporation (BOXL) Prices $5.0 Million Registered Direct Offering of Common Stock, Warrants
-
Boxlight Announces Pricing of $5.0 Million Registered Direct Offering
-
Navidea Biopharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
Performance Shipping (PSHG) Prices Direct Offering at $0.35/Share with Warrants
-
Performance Shipping Inc. Announces Pricing of $5.95 Million Registered Direct Offering and Concurrent Private Placement
-
United Maritime (USEA) Prices $26 Million Public Offering of Common Shares, Warrants
-
United Maritime Announces Pricing of $26.0 Million Public Offering
-
scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion
-
Nano Labs Ltd (NA) IPO Opens 34% Lower
-
BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia
-
Nano Labs Ltd (NA) Prices 1.77M ADS IPO at $11.50/ADS
-
Nano Labs Ltd Announces Pricing of Initial Public Offering
-
Nano Labs Ltd Announces Pricing of Initial Public Offering
-
Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management
-
Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET
-
Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET
-
CareCloud to Present at the Healthcare IT Conference Presented by Maxim Group LLC on Tuesday, July 12 at 11:00 a.m. EDT
-
CareCloud to Present at the Healthcare IT Conference Presented by Maxim Group LLC on Tuesday, July 12 at 11:00 a.m. EDT
-
Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch
-
Agile Therapeutics to Participate in Maxim Group’s Upcoming Women’s Health Panel
-
Agile Therapeutics to Participate in Maxim Group’s Upcoming Women’s Health Panel
-
Sphere 3D Corp. Provides Bitcoin Production and Mining Updates for June 2022
-
Kalera Public (KAL) Announces 2.5M Share and Warrant Placement at $4/sh
-
Kalera Public Limited Company Announces $10.0 Million Private Placement
-
Kalera Public Limited Company Announces $10.0 Million Private Placement
-
Daré Bioscience to Participate in Maxim Group Women’s Health Panel
-
Nano Labs Ltd (NA) Announces 1.77M ADS IPO at $11.35-$11.51/sh
-
Biolase (BIOL) Prices 1.4M Share At-the-market Offering at $4.625/sh
-
BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market
-
M-Vest and Maxim Group LLC to Host a panel discussion on Innovations in ALS: Exploring New Treatments In Development on Tuesday, June 28th at 11 A.M. EDT
-
Clene to Participate in Panel Discussion About Innovations in ALS Presented by Maxim Group and Hosted by M-Vest on June 28
-
Clene to Participate in Panel Discussion About Innovations in ALS Presented by Maxim Group and Hosted by M-Vest on June 28
-
Lion to Participate in Upcoming Maxim Conference on June 23, 2022
-
NeuroSense CEO to be Panelist at Maxim Group's Innovations in ALS: Exploring New Treatments In Development on June 28, 2022
-
Intchains Group Limited (ICG) Files for Proposed ADS IPO
-
M-Vest Events – Digital Assets: Exploring the Metaverse and Crypto Assets
-
LM Funding America, Inc. to Participate in the Digital Assets: Exploring The Metaverse & Crypto Assets Conference Presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 23rd at 10 A.M
-
ReShape Lifesciences Inc. (RSLS) Announces $2.5M Warrant Exercise Transaction
-
ReShape Lifesciences Inc. (RSLS) Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds
-
ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds
-
ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds
-
The Digital Assets: Exploring The Metaverse And Crypto Assets Conference Powered by M-Vest Events to be held on June 23
-
Zedge To Participate in the Digital Assets: Exploring The Metaverse & Crypto Assets Conference Presented by Maxim Group
-
Nacuity Pharmaceuticals Announces $16.5 Million Series B Financing Led by Foundation Fighting Blindness & RD Fund
-
Nacuity Pharmaceuticals Announces $16.5 Million Series B Financing Led by Foundation Fighting Blindness & RD Fund
-
CryptoNewsBreaks – IBN to Sponsor Upcoming Digital Assets: Exploring The Metaverse & Crypto Assets Conference
-
WISeKey to Participate in the “Digital Assets: Exploring the Metaverse & Crypto Assets” Conference Presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 23

